• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Evonik

    Biosplice Initiates Phase 1 Trial For Cirtuvivint And Olaparib

    GLOBENEWSWIRE

    1st Patient Dose in Trial of Biosplice`s Cirtuvivint for Leukemia

    GLOBENEWSWIRE

    Biosplice: First Patient Dosed in Phase 2 Trial of Cirtuvivint

    GLOBENEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.